Action ZyVersa Therapeutics - ZVSA

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

1,07

Prix Achat

1,07

Prix Vente

1,12

Volume échangé

75 391

1,06 Fourchette du Jour 1,1349

0,9801 Plage de 52 semaines 25,00

Cap du marché

2,508M

Clôture Veille

1,15

Ouverture

1,11

Dernière Transaction

100

1.07

Dernière heure de transaction

18:19:21

Volume financier

US$ 83 098

VWAP

1,1022

Volume moyen (3 m)

1 373 895

Actions en circulation

2 344 191

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,50

Bénéfice par action (BPA)

-45,32

Chiffre d'affairess

Bénéfice net

-106,25M

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medi... ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases. Show more

Secteur

Pharmaceutical Preparations

Industrie

Blank Checks

Site Web

www.zyversa.com

Siège social

Wilmington, Delaware, USA

Fondé

2022

ZyVersa Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ZVSA. Le dernier cours de clôture d'ZyVersa Therapeutics était de US$1,15. Au cours de la dernière année, les actions de ZyVersa Therapeutics ont été négociées dans une fourchette de prix de US$ 0,9801 à US$ 25,00.

ZyVersa Therapeutics compte actuellement 2 344 191 actions en circulation. La capitalisation boursière d'ZyVersa Therapeutics est de US$2,70 million. ZyVersa Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.50.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form PRE 14A - Other preliminary proxy statements

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco

ZyVersa is advancing a pipeline of first-in-class drug candidates built around two proprietary technologies. - Inflammasome ASC Inhibitor IC 100 designed to attenuate initiation and perpetuation...

ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial

Strokes affect 795,000 people annually in the US. Obesity, a top risk factor for strokes, is associated with around one out of five strokes.Cardiac complications following a stroke are a leading...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.06	-5.30973451327	1.13	1.2862	1	88141	1.16874621	CS
4	-0.0158	-1.45514827777	1.0858	1.42	0.9801	163565	1.15138713	CS
12	-1.17	-52.2321428571	2.24	3.37	0.9801	1373895	2.33649812	CS
26	-2.58	-70.6849315068	3.65	6.3	0.9801	706495	2.50830641	CS
52	-8.129	-88.3683009023	9.199	25	0.9801	1108191	7.11004613	CS
156	-4898.93	-99.9781632653	4900	5232.5	0.9801	1968501	79.92386347	CS
260	-4898.93	-99.9781632653	4900	5232.5	0.9801	1968501	79.92386347	CS

ZVSA - Frequently Asked Questions (FAQ)

What is the current ZyVersa Therapeutics share price?

The current share price of ZyVersa Therapeutics is US$ 1,07

How many ZyVersa Therapeutics shares are in issue?

ZyVersa Therapeutics has 2 344 191 shares in issue

What is the market cap of ZyVersa Therapeutics?

The market capitalisation of ZyVersa Therapeutics is USD 2,7M

What is the 1 year trading range for ZyVersa Therapeutics share price?

ZyVersa Therapeutics has traded in the range of US$ 0,9801 to US$ 25,00 during the past year

What is the PE ratio of ZyVersa Therapeutics?

The price to earnings ratio of ZyVersa Therapeutics is -0,5

What is the reporting currency for ZyVersa Therapeutics?

ZyVersa Therapeutics reports financial results in USD

What is the latest annual profit for ZyVersa Therapeutics?

The latest annual profit of ZyVersa Therapeutics is USD -106,25M

What is the registered address of ZyVersa Therapeutics?

The registered address for ZyVersa Therapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

What is the ZyVersa Therapeutics website address?

The website address for ZyVersa Therapeutics is www.zyversa.com

Which industry sector does ZyVersa Therapeutics operate in?

ZyVersa Therapeutics operates in the BLANK CHECKS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
NXUNXU Inc	US$ 1,6699 (586,07%)	421,64M
WATTEnergous Corporation	US$ 1,461 (255,30%)	164,41M
INTZIntrusion Inc	US$ 5,53 (156,02%)	114,5M
HOLOMicroCloud Hologram Inc	US$ 4,52 (88,33%)	99,55M
CYNCYNGN Inc	US$ 1,1699 (86,32%)	60,74M
ABPAbpro Holdings Inc	US$ 2,0501 (-54,34%)	1,39M
TRAWTraws Pharma Inc	US$ 7,825 (-41,69%)	896,28k
LITMSnow Lake Resources Ltd	US$ 1,1168 (-30,20%)	44,58M
LGHLWLion Group Holding Ltd	US$ 0,0052 (-25,71%)	54,82k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	US$ 66,74 (-24,56%)	8,96k
NXUNXU Inc	US$ 1,6699 (586,07%)	421,64M
VINCVincerx Inc	US$ 0,3519 (81,39%)	296,96M
XTIAXTI Aerospace Inc	US$ 0,0398 (0,76%)	184,49M
WATTEnergous Corporation	US$ 1,461 (255,30%)	164,41M
SMXSMX Security Matters Public Company	US$ 0,58 (64,03%)	132,06M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ZyVersa Therapeutics Inc (ZVSA) Cours

ZyVersa Therapeutics Inc (ZVSA)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de ZyVersa Therapeutics Inc

ZVSA Dernières nouvelles

ZVSA - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application